Tuesday, 14 May 2024 | 15:30 - 16:30
Session 4: Sponsor driven clinical trials
Format:In-person
Speakers (for more info see here):
-
Mark Higgins: Cystic Fibrosis: A model of precision medicine in rare disease. Vertex Pharmaceuticals. UK
-
Bianca Tan: Multidisciplinary therapy development for rare diseases: the example of Pulmonary Arterial Hypertension. AOP Orphan Pharmaceuticals. UK
-
TBA